HIF-2α-dependent induction of miR-29a restrains T<sub>H</sub>1 activity during T cell dependent colitis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39271652.
- Also identified by DOI 10.1038/s41467-024-52113-y and PMC identifier 11399416.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Metabolic imbalance leading to inflammatory hypoxia and stabilization of hypoxia-inducible transcription factors (HIFs) is a hallmark of inflammatory bowel diseases. We hypothesize that HIF could be stabilized in CD4<sup>+</sup> T cells during intestinal inflammation and alter the functional responses of T cells via regulation of microRNAs. Our assays reveal markedly increased T cell-intrinsic hypoxia and stabilization of HIF protein during experimental colitis. microRNA screen in primary CD4<sup>+</sup> T cells points us towards miR-29a and our subsequent studies identify a selective role for HIF-2α in CD4-cell-intrinsic induction of miR-29a during hypoxia. Mice with T cell-intrinsic HIF-2α deletion display elevated T-bet (target of miR-29a) levels and exacerbated intestinal inflammation. Mice with miR-29a deficiency in T cells show enhanced intestinal inflammation. T cell-intrinsic overexpression of HIF-2α or delivery of miR-29a mimetic dampen T<sub>H</sub>1-driven colitis. In this work, we show a previously unrecognized function for hypoxia-dependent induction of miR-29a in attenuating T<sub>H</sub>1-mediated inflammation.
Medical subject headings
- MicroRNAs
- Basic Helix-Loop-Helix Proteins
- Colitis
- Th1 Cells